All News

    The Benefit of Clinical Trial Enrollment for Patients With Cancer

    April 2nd 2025, 8:00pm

    Video

    There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.

    Addressing Gaps, Challenges and Disparities in AYA Cancer Care

    April 2nd 2025, 7:00pm

    Article

    Adolescent and young adult patients with cancer face delayed diagnoses, financial hardships and gaps in specialized care, creating a need for tailored support.

    Unexpected Challenges 11 Years After Breast Cancer

    April 2nd 2025, 5:20pm

    Article

    Eleven years post diagnosis and issues related to breast cancer still frustrate me.

    Camrelizumab Combo Doubles 5-Year Survival in Phase 3 Lung Cancer Trial

    April 2nd 2025, 4:35pm

    Article

    Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a Phase 3 trial.

    A New Comprehensive Hereditary Cancer Solution Has Been Launched

    April 2nd 2025, 3:00pm

    Article

    A new comprehensive hereditary cancer solution offers genetic counseling and multigene panels to enhance early detection of disease's like brain cancer.

    NeuroSAFE Increases Erectile Function After Prostate Cancer Surgery

    April 2nd 2025, 1:00pm

    Video

    Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.

    What Role Does MRD Play in Multiple Myeloma Treatment Decision Making?

    April 1st 2025, 9:00pm

    Article

    Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.

    Dive Into March 2025 FDA Approvals Across Cancer Subtypes

    April 1st 2025, 7:05pm

    Article

    Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal cancers.

    What To Know About Having Radiation for Metastatic Prostate Cancer

    April 1st 2025, 5:49pm

    Article

    As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical challenges.

    First Patient Dosed With Annamycin and Cytarabine in Phase 3 AML Trial

    April 1st 2025, 4:24pm

    Article

    The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the global phase 3 MIRACLE trial.